Inventor · disambiguated record
Mark Elban
Also filed as: ELBAN MARK · ELBAN MARK ANDREW
2 granted patents·6 pending applications·1 citations·filing 2015–2025
36Inventor score
Top patents by PatentIndex Score
8 records- 0171US2024352034A1Hydroxypyridoxazepines as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0262US2025313573A1Hydroxypyridoxazepines as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2025·Application pending·0 cites
- 0361US10450288B2Hydroxy formamide derivatives and their useGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Oct 22, 2019·1 cites·40 claims
- 0457US11945826B2Hydroxypyridoxazepines as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Apr 2, 2024·0 cites·31 claims
- 0554US2020095217A1Hydroxy formamide derivatives and their useGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 0650US2024083896A1Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 InhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0744US2023103791A12,3-dihydroquinazolin compounds as nav1.8 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Application pending·0 cites
- 0830US2018362485A1N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORSGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Elban files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →